[HTML][HTML] Percutaneous transcatheter closure of congenital ventricular septal defects

J Song - Korean Circulation Journal, 2023 - ncbi.nlm.nih.gov
Ventricular septal defects (VSDs) are the most common kind of congenital heart disease
and, if indicated, surgical closure has been accepted as a gold-standard treatment …

[HTML][HTML] Comparative outcomes of two competitive devices for retrograde closure of perimembranous ventricular septal defects

RN Haddad, ZS Saliba - Frontiers in Cardiovascular Medicine, 2023 - ncbi.nlm.nih.gov
Background Retrograde closure of perimembranous ventricular septal defects (pmVSDs) is
a well-established procedure. However, interventionists are still looking for the best closure …

[HTML][HTML] Off-label use of Lifetech KONAR-MF™ ventricular septal defect occluder for large patent ductus arteriosus closure in< 6​ kg infants

CG Gronier, N Benbrik, B Romefort, S Prigent… - International Journal of …, 2022 - Elsevier
Background Device PDA closure is increasingly used in smaller patients. Major safety
concerns remain when applied to< 6​ kg infants with large PDA and challenging anatomy …

[PDF][PDF] Interventional device closure of perimembranous ventricular septal defects: challenges, pitfalls, and advancements in device technology

RN Haddad, Z Saliba - Interv Cardiol, 2021 - academia.edu
Percutaneous closure is the standard therapy for muscular Ventricular Septal Defects
(VSDs) beyond infancy with a low rate of major complications. The story is somewhat …

[PDF][PDF] Cierre percutáneo de comunicación interventricular (CIV) perimembranosa

LT Quiñonero - serviciopediatria.com
Diapositiva 1 Page 1 Cierre percutáneo de comunicación interventricular (CIV)
perimembranosa Lorena Tudela Quiñonero (Rotatorio Pediatría) Tutor: Ismael Martín de Lara …

[引用][C] Transcatheter Closure of a Large Muscular Ventricular Septal Defect (VSD) in a Child Weighing Five Kilogram with Severe Pulmonary Arterial Hypertension

NNF Begum